Nivolumab in combination with CIMAvax-EGF for lung cancer

Bookmark and Share
Published: 4 Jan 2019
Views: 1205
Dr Grace Dy - Roswell Park Cancer Institute, USA

Dr Grace Dy talks to ecancer at II Congreso oncológico ecancer-Liga Colombiana contra el Cáncer 2018 in Bogotá, Colombia.

She discusses the highlights from a Phase I study using nivolumab in combination with CIMAvax-EGF, which demonstrated that the dosages were safe.